BIO is pleased to announce the Summit program and list of confirmed panelists.

Tuesday, October 14, 2014
12:30 – 1:45 PM Keynote Lunch: Vision for the 21st Century Cures Initiative
• Moderator: Paul Hastings, Chairman and CEO, OncoMed Pharmaceuticals • Representative Diana DeGette (D-CO) (Invited)
• Representative Joe Pitts (R-PA)
 2:00 – 3:15 PM 21st Century Cures: Ensuring Patient Engagement in the Discovery, Development and Delivery of New Treatments

• Moderator: Jeanne Haggerty, Vice President, Federal Government Relations, BIO
• Jeff Allen, PhD, Executive Director, Friends of Cancer Research
• Clay Alspach, JD, Chief Counsel for the Subcommittee on Health, US House Energy and Commerce Committee
• Robert Metcalf, PhD, Vice President, Global Regulatory Affairs, Eli Lilly & Company (Invited) • Rachel Stauffer, Health Legislative Assistant     for Representative Diana DeGette (D-CO)
• Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA
3:30 – 4:45 PM Preserving Patient Access to Innovative Treatments
• Moderator: Kristine Peterson, CEO, Valeritas Inc.
• Elizabeth Carpenter, Director, Avalere Health
• Leah McCormick Howard, JD, Director, Government Relations and Advocacy, National Psoriasis Foundation
• Bernadette O’Donoghue, Executive Director, Policy Development & Regulatory Affairs, The Leukemia & Lymphoma Society

Wednesday, October 15, 2014
9:30-9:45AM Welcome Remarks by Richard Pops, Chairman & CEO, Alkermes

9:45-11:00AM Patient-SponsoredRegistries:From“OurData”to“BigData”

    • Moderator: Richard Pops, Chairman & CEO, Alkermes
• Sally Okun, RN, MMHS, Vice President, Advocacy, Policy, & Patient Safety, PatientsLikeMe
• Yaffa Rubinstein, MS, PhD, Director, Patient Resources for Clinical and Translational Research, Office of Rare Diseases Research, NCATS, NIH
11:15 – 12:30 PM Empowering the Patient: Collaborative Approaches to Improve Drug Development

• Moderator: Andrew Womack, PhD, Director, Science & Regulatory Affairs, BIO

• Pat Furlong, Founding President and CEO, Parent Project Muscular Dystrophy
• Kimberly McCleary, Director of Strategic Initiatives, FasterCures • John Walsh, President and CEO, Alpha-1 Foundation
Information on additional speakers to follow!
Questions? Contact Gautami Inamdar at ginamdar@bio.org

X